Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-doses Alemtuzumab and Rituximab Combination as First Line Treatment in Aplastic Anemia

NCT01408342 is registered in ClinicalTrials.gov with Hospital Universitario Dr. Jose E. Gonzalez as lead sponsor.

NCT NCT01408342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01408342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-doses Alemtuzumab and Rituximab Combination as First Line Treatment in Aplastic Anemia
Lead sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Phase
Not applicable
Overall status
Withdrawn
Start date
July 31, 2011
Completion date
January 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aplastic anemia